Variant report
Variant | nsv521103 |
---|---|
Chromosome Location | chr7:3860836-3868788 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:3848437..3851053-chr7:3868632..3870528,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2341959 | chr7:3860836-3860837 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs570084199 | chr7:3860845-3860846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71524018 | chr7:3860861-3860862 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs148357507 | chr7:3860870-3860871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs67807489 | chr7:3860873-3860874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559814786 | chr7:3860906-3860907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573358487 | chr7:3860910-3860911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78854802 | chr7:3860913-3860914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556005426 | chr7:3860922-3860923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562277506 | chr7:3860927-3860928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531024683 | chr7:3860935-3860936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551239788 | chr7:3860938-3860939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564652585 | chr7:3860939-3860940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533360682 | chr7:3860943-3860944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574287395 | chr7:3860950-3860951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566881621 | chr7:3860969-3860970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535905260 | chr7:3861023-3861024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372032373 | chr7:3861032-3861033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368593218 | chr7:3861063-3861064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370075198 | chr7:3861082-3861083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371315358 | chr7:3861088-3861089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143959434 | chr7:3861091-3861092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368143955 | chr7:3861096-3861097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201959269 | chr7:3861112-3861113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146423033 | chr7:3861113-3861114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139888545 | chr7:3861115-3861116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs199853513 | chr7:3861116-3861117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139540390 | chr7:3861129-3861130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs59492170 | chr7:3861136-3861137 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs200525638 | chr7:3861142-3861143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201492847 | chr7:3861148-3861149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145830129 | chr7:3861149-3861150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148973866 | chr7:3861181-3861182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188954051 | chr7:3861183-3861184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573321623 | chr7:3861187-3861188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375534283 | chr7:3861197-3861198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145476836 | chr7:3861230-3861231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369241949 | chr7:3861232-3861233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372714866 | chr7:3861234-3861235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556017068 | chr7:3861244-3861245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375744884 | chr7:3861246-3861247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575771397 | chr7:3861259-3861260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369867651 | chr7:3861260-3861261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190961883 | chr7:3861264-3861265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564791686 | chr7:3861301-3861302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533626663 | chr7:3861305-3861306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10240325 | chr7:3861333-3861334 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs529321474 | chr7:3861342-3861343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182839338 | chr7:3861350-3861351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6943646 | chr7:3861353-3861354 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Chordoma | 21602918 | CNVD |
Lynch syndrome | 22585707 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Breast cancer | 16397240 | CNVD |
Raine Syndrome | 17924334 | CNVD |
Diffuse large b-cell lymphoma | 21266526 | CNVD |
Melanoma | 18172304 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Glioma | 18556773 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Mental retardation | 17901693 | CNVD |
Heart disease | 21282601 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:3848400-3882000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr7:3849400-3880600 | Weak transcription | Aorta | Aorta |
3 | chr7:3859800-3861000 | Enhancers | Pancreas | Pancrea |
4 | chr7:3860400-3861000 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr7:3860800-3861200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
6 | chr7:3860800-3861400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr7:3860800-3861400 | Enhancers | Adipose Nuclei | Adipose |
8 | chr7:3861000-3886400 | Weak transcription | Pancreas | Pancrea |
9 | chr7:3861200-3865600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
10 | chr7:3864000-3865600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr7:3864000-3865800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr7:3864200-3864800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr7:3864200-3865600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr7:3864200-3865600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr7:3864400-3865000 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr7:3864400-3866000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr7:3864600-3865400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr7:3864600-3865600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr7:3864600-3865800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr7:3864600-3866000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr7:3865000-3865400 | Weak transcription | H1 Cell Line | embryonic stem cell |
22 | chr7:3865200-3866000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
23 | chr7:3865400-3865800 | Enhancers | H1 Cell Line | embryonic stem cell |
24 | chr7:3865600-3866000 | Enhancers | Rectal Mucosa Donor 31 | rectum |